Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cambridge Cognition HoldingsLSE:COG 47 Cash Ratio is 0.14 as of Dec. 2025, which is 64% below its 10-year median of 0.39. GuruFocus rates LSE:COG with a GF Score™ of 47/100 and a GF Value™ of £0.33 (Fairly Valued). The stock has 5 warning signs investors should review. Among 663 Healthcare Providers & Services companies, Cambridge Cognition Holdings ranks worse than 83.41% on this metric.
Cambridge Cognition Holdings has a Cash Ratio of 0.14. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Cambridge Cognition Holdings's Cash Ratio or its related term are showing as below:
LSE:COG'
s Cash Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.39 Max: 1.2
Current: 0.14
During the past 13 years, Cambridge Cognition Holdings's highest Cash Ratio was 1.20. The lowest was 0.14. And the median was 0.39.
LSE:COG's Cash Ratio is ranked worse than 83.41% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: 0.59
vs LSE:COG: 0.14
Cambridge Cognition Holdings (LSE:COG) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Cambridge Cognition Holdings Cash Ratio Related Terms
Cambridge Cognition Holdings Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Cambridge Cognition Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Cognition Holdings Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cambridge Cognition Holdings's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Cambridge Cognition Holdings's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Cognition Holdings (LSE:COG) has a Cash Ratio of 0.14 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cambridge Cognition Holdings and its competitors. This is 64% below median its historical median of 0.39. Over the past decade, Cambridge Cognition Holdings' Cash Ratio has ranged from 0.14 to 1.20. According to the industry distribution chart, Cambridge Cognition Holdings ranks #553 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Cambridge Cognition Holdings' Cash Ratio too high?
Cambridge Cognition Holdings' current Cash Ratio of 0.14 is 64% below median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 1.20. The Healthcare Providers & Services industry median Cash Ratio is 0.59. Cambridge Cognition Holdings' value of 0.14 is 76.3% below this industry median. Based on the distribution chart, Cambridge Cognition Holdings ranks #553 out of 663 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cambridge Cognition Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cambridge Cognition Holdings' Cash Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cambridge Cognition Holdings ranks #553 out of 663 companies for Cash Ratio. This places Cambridge Cognition Holdings in the lower half of its industry. The industry median Cash Ratio is 0.59. Cambridge Cognition Holdings' value of 0.14 is 76.3% below this benchmark. Historically, Cambridge Cognition Holdings' own Cash Ratio has ranged from 0.14 to 1.20 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.59, Cambridge Cognition Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.59, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cambridge Cognition Holdings's current Cash Ratio of 0.14 is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cambridge Cognition Holdings and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Cognition Holdings's current Cash Ratio is 0.14, which is 64% below median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Cognition Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Cognition Holdings (LSE:COG) is currently considered Fairly Valued. The stock's GF Value™ is £0.33, compared to a current price of £0.33 — trading 1.5% below its estimated fair value. The current Cash Ratio is 0.14, which is 64% below median its 10-year median of 0.39 and 76.3% below the Healthcare Providers & Services industry median of 0.59. Cambridge Cognition Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Cambridge Cognition Holdings (LSE:COG), the current Cash Ratio is 0.14 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?
Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be undervalued.
The current stock price of £0.33 is trading 1.5% below its estimated GF Value™ of £0.33.
GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.
Key valuation signals for LSE:COG:
Cash Ratio: 0.14 (64% below median its 10-year median of 0.39)
GF Value™: £0.33 vs. price of £0.33 (1.5% below fair value)
Industry Position: 76.3% below the Healthcare Providers & Services median (#553 of 663)
No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
47GF Score
Get the complete analysis for LSE:COG
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:COG has been successfully added to your 
